November 12, 2024 Asieris Unveils Results for the First Time at 2024 IPVC the Analysis of the of HPV Clearance Rate for Different HPV Types and Different Follow-up Times of the Non-Surgical Treatment for Cervical HSIL Product APL-1702 Clinical Study
November 7, 2024 Asieris Pharmaceuticals and China Women’s Development Foundation Sign Strategic Cooperation Agreement for ‘Fertility-Friendly Cervical Health Initiative’
November 6, 2024 Cancer Foundation of China and Asieris Pharmaceuticals Forge Strategic Partnership for Cervical Cancer Prevention and Control
November 5, 2024 Asieris Showcases World’s 1st Product for Non-Invasive Treatment of Precancerous Cervical Lesions at its CIIE Debut